GO
Loading...

Celgene Corp

More

  • Final Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 6:02 PM ET

    Amgen Inc. rose$. 54 or. 5 percent, to $115.54. Biogen Idec rose $5.99 or 2.1 percent, to $291.48. Celgene Corp. rose $2.02 or 1.4 percent, to $141.86.

  • Midday Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 1:30 PM ET

    Amgen Inc. rose$. 17 or. 1 percent, to $115.17. Biogen Idec rose $5.59 or 2.0 percent, to $291.08. Celgene Corp. rose $1.52 or 1.1 percent, to $141.36.

  • Early Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 10:27 AM ET

    Amgen Inc. fell$. 34 or. 3 percent, to $114.67. Biogen Idec rose $2.08 or. 7 percent, to $287.57. Celgene Corp. rose $1.35 or 1.0 percent, to $141.19.

  • Final Glance: Biotechnology companies Monday, 14 Apr 2014 | 6:01 PM ET

    Amgen Inc. rose $1.38 or 1.2 percent, to $113.32. Biogen Idec rose $5.52 or 2.0 percent, to $279.52. Celgene Corp. rose $1.16 or. 8 percent, to $138.06.

  • Midday Glance: Biotechnology companies Monday, 14 Apr 2014 | 2:08 PM ET

    Amgen Inc. rose $2.12 or 1.9 percent, to $114.06. Biogen Idec rose $6.40 or 2.3 percent, to $280.40. Celgene Corp. rose $1.64 or 1.2 percent, to $138.54.

  • Early Glance: Biotechnology companies Monday, 14 Apr 2014 | 10:21 AM ET

    Amgen Inc. rose$. 01 or percent, to $111.95. Biogen Idec rose $3.06 or 1.1 percent, to $277.06. Celgene Corp. rose $1.60 or 1.2 percent, to $138.50.

  • Final Glance: Biotechnology companies Friday, 11 Apr 2014 | 6:02 PM ET

    Amgen Inc. fell $2.17 or 1.9 percent, to $111.94. Biogen Idec fell $13.35 or 4.6 percent, to $274.00. Celgene Corp. fell $3.08 or 2.2 percent, to $136.90.

  • Midday Glance: Biotechnology companies Thursday, 10 Apr 2014 | 1:34 PM ET

    Amgen Inc. fell $5.13 or 4.3 percent, to $114.87. Biogen Idec fell $14.41 or 4.8 percent, to $286.27. Celgene Corp. fell $6.28 or 4.3 percent, to $141.04.

  • Early Glance: Biotechnology companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Amgen Inc. fell$. 94 or. 8 percent, to $119.06. Biogen Idec fell $9.27 or 3.1 percent, to $291.41. Celgene Corp. fell $2.36 or 1.6 percent, to $144.96.

  • Final Glance: Biotechnology companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Amgen Inc. rose $2.02 or 1.7 percent, to $120.00. Biogen Idec rose $14.76 or 5.2 percent, to $300.68. Celgene Corp. rose $9.10 or 6.6 percent, to $147.32.

  • US stocks rally on Fed minutes, earnings news Wednesday, 9 Apr 2014 | 9:16 AM ET

    NEW YORK— Once again, it was the Federal Reserve to the rescue for the stock market. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent.

  • Early Glance: Biotechnology companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Amgen Inc. rose$. 10 or. 1 percent, to $118.92. Biogen Idec fell $4.31 or 1.5 percent, to $289.88. Celgene Corp. fell $1.32 or. 9 percent, to $137.84.

  • There’s still value in biotech stocks: Citi pro Monday, 7 Apr 2014 | 6:23 PM ET

    Despite the recent meltdown in biotech, there are still areas of opportunity within the sector, Citi's Yaron Werber says.

  • Final Glance: Biotechnology companies Monday, 7 Apr 2014 | 6:01 PM ET

    Amgen Inc. fell$. 29 or. 2 percent, to $118.82. Biogen Idec rose $5.92 or 2.1 percent, to $294.19. Celgene Corp. rose $1.78 or 1.3 percent, to $139.16.

  • Midday Glance: Biotechnology companies Monday, 7 Apr 2014 | 1:49 PM ET

    Amgen Inc. fell$. 47 or. 4 percent, to $118.64. Biogen Idec rose $4.41 or 1.5 percent, to $292.68. Celgene Corp. rose$. 89 or. 6 percent, to $138.27.

  • Final Glance: Biotechnology companies Friday, 4 Apr 2014 | 6:19 PM ET

    Amgen Inc. fell $5.02 or 4.0 percent, to $119.11. Biogen Idec fell $13.59 or 4.5 percent, to $288.27. Celgene Corp. fell $6.22 or 4.3 percent, to $137.38.

  • *E* Trade and Netflix weigh on S&P 500 and Nasdaq. NEW YORK, April 4- U.S. stocks fell sharply on Friday as momentum shares like Netflix and TripAdvisor sold off for a second straight session, putting the Nasdaq on track for its second-worst day of the year.

  • *E* Trade and Netflix weigh on S&P 500 and Nasdaq. NEW YORK, April 4- The Nasdaq tumbled more than 2 percent on Friday as momentum stocks like Netflix and TripAdvisor sold off for a second straight session.

  • Midday Glance: Biotechnology companies Friday, 4 Apr 2014 | 1:20 PM ET

    Amgen Inc. fell $2.97 or 2.4 percent, to $121.16. Biogen Idec fell $13.57 or 4.5 percent, to $288.29. Celgene Corp. fell $5.09 or 3.5 percent, to $138.51.

  • *E* Trade and Netflix weigh on the S&P 500 and the Nasdaq. NEW YORK, April 4- The Nasdaq tumbled more than 2 percent on Friday, led by another selloff in momentum stocks like Netflix and TripAdvisor, as investors ignored relatively strong March jobs data. Biogen Idec Inc fell 3.6 percent to $291.

Most Popular Video

Thursday, 17 Apr 2014 | 3:00 AM ET

European shares opened mixed on Thursday, failing to continue a rally on Wall Street after accommodative comments from U.S. Federal Reserve Chair Janet Yellen.

Thursday, 17 Apr 2014 | 2:10 AM ET

Bill McDermott, co-CEO of SAP, says cloud computing is "growing faster than everything else" in the company.

Thursday, 17 Apr 2014 | 1:50 AM ET

Edward George, head of soft commodities at Ecobank, says chocolate will become a luxury in Europe as cocoa prices shoot up.